USP37 and cancer: These findings are consistent with previous reports in other tumors suggesting that USP37 (Cao et al., 2023; Wu et al., 2021; Chauhan et al., 2023; Stromberg et al., 2021; Hernandez-Perez et al., 2016), as a deubiquitinating enzyme, may stabilize proteins involved in cell cycle progression and survival, contributing to uncontrolled cell proliferation, and plays a multifaceted role in cancer progression.